<?xml version="1.0" encoding="UTF-8"?>
<p>Co-infections and superinfections with bacterial and viral pathogens represent a significant challenge in myriad life-threatening conditions and illnesses, including toxic shock syndrome [
 <xref rid="ppat.1008393.ref001" ref-type="bibr">1</xref>,
 <xref rid="ppat.1008393.ref002" ref-type="bibr">2</xref>], sepsis [
 <xref rid="ppat.1008393.ref003" ref-type="bibr">3</xref>,
 <xref rid="ppat.1008393.ref004" ref-type="bibr">4</xref>], and influenza A virus (IAV) epidemics and pandemics [
 <xref rid="ppat.1008393.ref005" ref-type="bibr">5</xref>–
 <xref rid="ppat.1008393.ref009" ref-type="bibr">9</xref>]. Some of the bacterial culprits, such as 
 <italic>Staphylococcus aureus</italic> and 
 <italic>Streptococcus pyogenes</italic>, secrete exotoxins that function as superantigens (SAgs) by virtue of their ability to bind the lateral surface of major histocompatibility complex (MHC) II molecules and polyclonally activate MHC-restricted CD4
 <sup>+</sup> (T
 <sub>CD4</sub>) and CD8
 <sup>+</sup> T cells (T
 <sub>CD8</sub>) bearing select T cell receptor (TCR) Vβ families [
 <xref rid="ppat.1008393.ref010" ref-type="bibr">10</xref>].
</p>
